Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.76 |
| ▸ | BACE2 | Q9Y5Z0 | 7/20 | 0.60 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.60 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.60 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.60 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.60 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.60 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL12478656 | 0.97 | BACE1 (0.72) | BACE1BACE2PSEN1PSEN2APH1B | |
| Formic Acid SCHEMBL12478650 | 0.97 | BACE1 (0.72) | BACE1BACE2PSEN1PSEN2APH1B | |
| SCHEMBL16204136 | 0.90 | BACE1 (0.78) | BACE1BACE2PSEN1PSEN2APH1B | |
| SCHEMBL360390 | 0.87 | BACE1 (1.00) | BACE1BACE2PSEN1PSEN2APH1B | |
| SCHEMBL2595368 | 0.87 | BACE1 (1.00) | BACE1BACE2PSEN1PSEN2APH1B | |
| SCHEMBL15976154 | 0.86 | BACE1 (0.79) | BACE1BACE2PSEN1PSEN2APH1B | |
| SCHEMBL12697037 | 0.85 | BACE1 (0.77) | BACE1BACE2APP | |
| SCHEMBL15703834 | 0.84 | BACE1 (0.81) | BACE1BACE2 | |
| SCHEMBL7710840 | 0.84 | BACE1 (0.81) | BACE1BACE2 | |
| SCHEMBL2590343 | 0.84 | BACE1 (0.86) | BACE1BACE2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815841-B2 | 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2014-08-26 | — | — | US | disclosed |